FAM76A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.417800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.131400E-01
Normal-vs-Stage2
5.577200E-01
Normal-vs-Stage3
7.578400E-02
Normal-vs-Stage4
1.916000E-01
Stage1-vs-Stage2
8.085600E-01
Stage1-vs-Stage3
1.168210E-01
Stage1-vs-Stage4
1.551760E-02
Stage2-vs-Stage3
1.252650E-01
Stage2-vs-Stage4
2.020000E-02
Stage3-vs-Stage4
9.099800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.560200E-01
Normal-vs-AfricanAmerican
6.453600E-01
Normal-vs-Asian
3.212200E-01
Caucasian-vs-AfricanAmerican
9.590000E-01
Caucasian-vs-Asian
2.379000E-01
AfricanAmerican-vs-Asian
4.908800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.533600E-01
Normal-vs-Female
6.487000E-01
Male-vs-Female
4.165200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.258000E-01
Normal-vs-Age(41-60Yrs)
6.794200E-01
Normal-vs-Age(61-80Yrs)
5.706400E-01
Normal-vs-Age(81-100Yrs)
2.864200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.943800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.550000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.355600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.761800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.191800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.093610E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.815980E-01
Normal-vs-Daily Drinker
4.377600E-01
Normal-vs-Weekly Drinker
7.506800E-01
Normal-vs-Occasional Drinker
9.390600E-01
Normal-vs-Social Drinker
6.487000E-01
Non Drinker-vs-Daily Drinker
3.779600E-01
Non Drinker-vs-Weekly Drinker
4.950400E-01
Non Drinker-vs-Occasional Drinker
9.383600E-03
Non Drinker-vs-Social Drinker
1.251180E-01
Daily Drinker-vs-Weekly Drinker
8.177600E-01
Daily Drinker-vs-Occasional Drinker
1.121450E-01
Daily Drinker-vs-Social Drinker
5.255600E-01
Weekly Drinker-vs-Occasional Drinker
4.701600E-01
Weekly Drinker-vs-Social Drinker
8.759400E-01
Occasional Drinker-vs-Social Drinker
3.693200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.211180E-01
Normal-vs-Grade 2
2.066200E-02
Normal-vs-Grade 3
3.599800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.099200E-03
Grade 1-vs-Grade 3
2.132800E-01
Grade 1-vs-Grade 4
1.211180E-01
Grade 2-vs-Grade 3
4.692200E-02
Grade 2-vs-Grade 4
2.066200E-02
Grade 3-vs-Grade 4
3.599800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.046200E-01
Normal-vs-NonDiabetic
4.080400E-01
Diabetic-vs-NonDiabetic
8.348200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.449800E-01
Normal-vs-NoPancreatitis
5.326200E-01
Pancreatitis-vs-NoPancreatitis
5.057400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.175000E-01
Normal-vs-N1
5.872600E-01
N0-vs-N1
7.756400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.453600E-01
Normal-vs-TP53-NonMutant
7.252800E-01
TP53-Mutant-vs-TP53-NonMutant
7.499200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
